GT Biopharma Stock Quote GTBP - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

2.16

Bid

2.11

Ask

2.18

Volume

8,815

2.05 Day's Range 2.18

1.95 52 Week Range 10.6599

Market Cap

4.826M

Previous Close

2.18

Open

2.14

Last Trade

2.15

Last Trade Time

12:48:53

Financial Volume

$ 18,794

VWAP

2.132

Average Volume (3m)

24,304

Shares Outstanding

2,234,328

Dividend Yield

PE Ratio

-0.64

Earnings Per Share (EPS)

-3.4

Revenue

Net Profit

-7.6M

GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cance... GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its key drug candidates are OXS-2175, targeting the treatment of triple-negative breast cancer; OXS-4235, targets the treatment of multiple myeloma and associated osteolytic lesions; and OXS-1550, targets cancer cells expressing the CD19 receptor and CD22 receptor. Its TriKE and TetraKE platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.gtbiopharma.com

Headquarters

Wilmington, Delaware, USA

Founded

GT Biopharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GTBP. The last closing price for GT Biopharma was $2.18. Over the last year, GT Biopharma shares have traded in a share price range of $ 1.95 to $ 10.6599.

GT Biopharma currently has 2,234,328 shares outstanding. The market capitalization of GT Biopharma is $4.87 million. GT Biopharma has a price to earnings ratio (PE ratio) of -0.64.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.06	2.85714285714	2.1	2.29	2.05	12034	2.16219586	CS
4	0.035	1.64705882353	2.125	2.3441	1.95	8050	2.1377654	CS
12	-1.5	-40.9836065574	3.66	3.74	1.95	24304	2.664136	CS
26	-2.27	-51.2415349887	4.43	10.6599	1.95	691301	7.12850347	CS
52	-5.34	-71.2	7.5	10.6599	1.95	399446	7.11807851	CS
156	-225.84	-99.0526315789	228	233.1	1.95	276924	34.81920169	CS
260	-162.84	-98.6909090909	165	591.993	1.95	314600	109.21975726	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GSIWGarden Stage Ltd	$ 5.94 (161.67%)	41.2M
ZEOZeo Energy Corporation	$ 2.4414 (114.16%)	54.06M
TBIOTelesis Bio Inc	$ 2.74 (101.47%)	41.55M
XCURExicure Inc	$ 3.70 (61.57%)	14.34M
EWTXEdgewise Therapeutics Inc	$ 28.0519 (47.10%)	7.93M
HAOHaoxi Health Technology Ltd	$ 0.7497 (-75.01%)	6.19M
XCHXCHG Ltd	$ 8.54 (-53.51%)	897.79k
GDHGGolden Heaven Group Holdings Ltd	$ 2.671 (-35.95%)	379.64k
BLMZBloomZ Inc	$ 0.885 (-35.40%)	509.53k
HOVRNew Horizon Aircraft Ltd	$ 0.48 (-35.22%)	1.92M
NVDANVIDIA Corporation	$ 119.16 (5.11%)	150.86M
SQQQProShares UltraPro Short QQQ	$ 7.67 (-8.69%)	133.7M
MAXNMaxeon Solar Technologies Ltd	$ 0.1065 (17.16%)	73.6M
FRGTFreight Technologies Inc	$ 0.1308 (5.57%)	70.78M
TSLATesla Inc	$ 242.71 (6.83%)	59.91M